Latest Insider Transactions at Editas Medicine, Inc. (EDIT)
This section provides a real-time view of insider transactions for Editas Medicine, Inc. (EDIT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Editas Medicine, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Editas Medicine, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 04
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
518
-0.39%
|
$1,554
$3.42 P/Share
|
|
Sep 04
2024
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
1,555
-0.49%
|
$4,665
$3.42 P/Share
|
|
Jul 25
2024
|
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
11,886
-13.98%
|
$59,430
$5.42 P/Share
|
|
Jul 19
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,619
-4.69%
|
$33,095
$5.21 P/Share
|
|
Jun 04
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
511
-0.36%
|
$2,555
$5.5 P/Share
|
|
Jun 04
2024
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
12,191
-3.72%
|
$60,955
$5.5 P/Share
|
|
May 20
2024
|
Erick Lucera EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
22,337
-16.05%
|
$111,685
$5.61 P/Share
|
|
May 13
2024
|
Jessica Hopfield Director |
BUY
Open market or private purchase
|
Direct |
45,000
+39.93%
|
$225,000
$5.64 P/Share
|
|
Mar 05
2024
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
77,824
-19.2%
|
$700,416
$9.42 P/Share
|
|
Mar 04
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,327
-12.56%
|
$182,943
$9.42 P/Share
|
|
Mar 02
2024
|
Erick Lucera EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
61,266
+19.75%
|
-
|
|
Mar 02
2024
|
Gilmore Neil O'Neill CEO |
BUY
Grant, award, or other acquisition
|
Direct |
275,125
+22.11%
|
-
|
|
Mar 02
2024
|
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,855
+20.61%
|
-
|
|
Mar 02
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
89,815
+17.34%
|
-
|
|
Dec 05
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
103
-0.14%
|
$1,030
$10.9 P/Share
|
|
Nov 14
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
695
-0.92%
|
$5,560
$8.21 P/Share
|
|
Nov 07
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
139
-0.18%
|
$1,112
$8.4 P/Share
|
|
Sep 06
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
103
-0.14%
|
$824
$8.82 P/Share
|
|
Aug 11
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
702
-0.92%
|
$5,616
$8.59 P/Share
|
|
Aug 08
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
141
-0.18%
|
$1,128
$8.39 P/Share
|
|
Jul 24
2023
|
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
45,167
+50.0%
|
-
|
|
Jul 19
2023
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,317
-5.65%
|
$34,536
$8.8 P/Share
|
|
Jun 05
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
105
-0.14%
|
$945
$9.5 P/Share
|
|
Jun 05
2023
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
6,486
-4.75%
|
$58,374
$9.5 P/Share
|
|
May 17
2023
|
Erick Lucera EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
77,900
+50.0%
|
-
|
|
May 11
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
668
-0.86%
|
$6,012
$9.87 P/Share
|
|
May 11
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
949
-0.88%
|
$8,541
$9.87 P/Share
|
|
May 09
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
135
-0.17%
|
$1,215
$9.51 P/Share
|
|
Mar 03
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
101
-0.13%
|
$808
$8.89 P/Share
|
|
Mar 03
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
184
-0.17%
|
$1,472
$8.89 P/Share
|
|
Mar 02
2023
|
Bruce Eaton EVP, CBO AND CTO |
BUY
Grant, award, or other acquisition
|
Direct |
16,700
+17.69%
|
-
|
|
Mar 02
2023
|
Gilmore Neil O'Neill CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.79%
|
-
|
|
Mar 02
2023
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+19.07%
|
-
|
|
Mar 02
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,500
+22.62%
|
-
|
|
Feb 13
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
3,307
-5.14%
|
$29,763
$9.67 P/Share
|
|
Feb 13
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,287
-5.32%
|
$38,583
$9.67 P/Share
|
|
Feb 13
2023
|
Mark S Shearman EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,790
-4.08%
|
$25,110
$9.67 P/Share
|
|
Feb 07
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
346
-0.54%
|
$3,806
$11.1 P/Share
|
|
Jan 10
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,752
-2.13%
|
$14,016
$8.16 P/Share
|
|
Dec 05
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
102
-0.16%
|
$1,020
$10.23 P/Share
|
|
Dec 05
2022
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
193
-0.23%
|
$1,930
$10.23 P/Share
|
|
Nov 08
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
289
-0.44%
|
$3,179
$11.02 P/Share
|
|
Sep 06
2022
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
192
-0.23%
|
$2,880
$15.01 P/Share
|
|
Sep 06
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
101
-0.16%
|
$1,515
$15.01 P/Share
|
|
Aug 09
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
293
-0.45%
|
$5,274
$18.6 P/Share
|
|
Jul 18
2022
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
58,372
+50.0%
|
-
|
|
Jun 15
2022
|
Mark S Shearman EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,145
-7.0%
|
$51,450
$10.06 P/Share
|
|
Jun 03
2022
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,527
-1.81%
|
$16,797
$11.54 P/Share
|
|
Jun 03
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
1,123
-1.69%
|
$12,353
$11.54 P/Share
|
|
Jun 02
2022
|
Gilmore Neil O'Neill CEO |
BUY
Grant, award, or other acquisition
|
Direct |
86,655
+50.0%
|
-
|